Security key
42225T107
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 55,255,926
- Total 13F value
- $132,053,597
- Share change
- -2,407,884
- Put/Call ratio
- 675%
- SEC-reported price per share
- $2.39
- Number of holders
- 136
- Value change
- -$6,516,575
- Number of buys
- 56
- Number of sells
- 75
- Shares outstanding
- 75,234,467
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
136
Top holders
10
HCAT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Health Catalyst, Inc. SEC filings
Health Catalyst, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 42225T107
Recent filing periods:
Ownership snapshot
Top reported holders of HCAT - Health Catalyst, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Mathew Paul Arens
Disclosed value leader
First Light Asset Managem...
Comparable rows
15/15
Latest evidence
01 Dec 2025
3/4/5
13F
Lead comparable stake: 15%
Showing 1-6 of 15 holder rows.
Quick read
Mathew Paul Arens leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Mathew Paul Arens's linked filing trail.
Comparable ownership
Top 5
Mathew Paul Arens
15%
Daniel D. Burton
1.9%
Kevin Lee Freeman
0.48%
David Coy Ross
0.27%
Daniel LeSueur
0.26%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Mathew Paul Arens |
3/4/5
Director, 10%+ Owner
|
15%
|
$32,429,283
10,955,839 shares
|
— | 01 Dec 2025 |
| Daniel D. Burton |
3/4/5
Chief Executive Officer, Director
|
1.9%
|
$4,040,265
1,393,099 shares
|
— | 01 Dec 2025 |
| Kevin Lee Freeman |
3/4/5
Chief Commercial Officer
|
0.48%
|
$1,040,261
358,686 shares
|
— | 01 Dec 2025 |
| David Coy Ross |
3/4/5
Chief Tech & Product Officer
|
0.27%
|
$686,727
204,219 shares
|
— | 02 Sep 2025 |
| Daniel LeSueur |
3/4/5
Chief Operating Officer
|
0.26%
|
$667,048
198,367 shares
|
— | 02 Sep 2025 |
| KANE JOHN A |
3/4/5
Director
|
0.23%
|
$643,610
170,719 shares
|
— | 09 Jul 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
136
Shares
55,255,926
Rows available
136
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
142
Q4 2025 holders
136
Holder diff
-6
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend